Changing T-cell enigma: cancer killing or cancer control? - Wikidata - wikimedia - TriplyDB

Changing T-cell enigma: cancer killing or cancer control?

Changing T-cell enigma: cancer killing or cancer control?

http://www.wikidata.org/entity/Q42287317

about

Immunotherapy of melanoma: efficacy and mode of action.IFNγ induces oxidative stress, DNA damage and tumor cell senescence via TGFβ/SMAD signaling-dependent induction of Nox4 and suppression of ANT2.Cytokine-induced senescence for cancer surveillance.

P2860

Q38682131-DAEC48C4-8B3E-49D4-91C0-A43D4E30324F Q38873861-FD4763B9-1015-4D4A-921D-2AFF4C3C2CF3 Q39229370-1635D242-C420-4FA5-B6C0-67B5CCEC3494

P2860

Changing T-cell enigma: cancer killing or cancer control?

http://www.wikidata.org/entity/Q42287317

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Changing T-cell enigma: cancer killing or cancer control?

@en

Changing T-cell enigma: cancer killing or cancer control?

@nl

type

label

Changing T-cell enigma: cancer killing or cancer control?

@en

Changing T-cell enigma: cancer killing or cancer control?

@nl

prefLabel

Changing T-cell enigma: cancer killing or cancer control?

@en

Changing T-cell enigma: cancer killing or cancer control?

@nl

P1433

Q42287317-F4491BC7-095C-43EF-AF82-54DF9B5670E1

P1476

Q42287317-13D6DE12-6457-4D91-9E49-F807D19904E4

P2093

Q42287317-00DBE720-AC11-4875-BD8E-61822EC775C5

Q42287317-644CDEBC-F384-4960-9F56-C2C329D927BD

Q42287317-69DFC135-CC52-44B6-B4C6-3A74C22203A9

Q42287317-B6FA99B9-42D0-42C6-B797-D3E4107F4891

Q42287317-F7FABE5C-28C7-46EC-B420-1DD3E134C1BA

P2860

Q42287317-03967C5F-0345-4750-91C4-8F98F2584769

Q42287317-05072810-18CA-4737-9E6A-52DDFF6C5964

Q42287317-0800882D-9B6E-4AD3-8460-108B600D455E

Q42287317-09AEEFA9-1DC3-4EC4-A176-B5C2E5653048

Q42287317-0ED35817-C70B-4493-9609-3E00BE7ED062

Q42287317-1119E591-65ED-48F5-BE20-583B7E577FCC

Q42287317-14D78A68-E8E6-4B9A-9794-5DCF63EACE00

Q42287317-18BF9E03-C552-421B-AD8B-B92F0715A15E

Q42287317-1D8DBA20-F31E-4199-BA9C-FF84DBE54EB2

Q42287317-21A2FB0A-61B8-476C-AD03-BFBE55275987

P304

Q42287317-9C1AAF8B-92A2-479E-A059-396E6AD8448A

P31

Q42287317-9BF0A839-1B34-400C-AB92-2B87B13334B4

P356

Q42287317-8F7956DC-D864-4011-8D57-8CD656EB188E

P433

Q42287317-661F8900-821F-425A-A30C-FA5AB15A5C31

P478

Q42287317-CF6B6709-6932-4D23-BDE4-8121E5EC3E7E

P577

Q42287317-36F14421-C3AA-4963-A49C-71CF22A5E2C1

P698

Q42287317-B4D03961-E872-47C1-9F9F-1F37D1879E9A

P932

Q42287317-BA169E34-3989-462C-B9BE-9E4768609E59

P356

P1433

P1476

Changing T-cell enigma: cancer killing or cancer control?

@en

P2093

Ellen Brenner

http://www.w3.org/2001/XMLSchema#string

Heidi Braumüller

http://www.w3.org/2001/XMLSchema#string

Lars Zender

http://www.w3.org/2001/XMLSchema#string

Martin Röcken

http://www.w3.org/2001/XMLSchema#string

Thomas Wieder

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer classification using the Immunoscore: a worldwide task force

Hallmarks of Cancer: The Next Generation

Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon

F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage

Combination anastrozole and fulvestrant in metastatic breast cancer

Abiraterone in metastatic prostate cancer without previous chemotherapy

Cancer regression in patients after transfer of genetically engineered lymphocytes

Trastuzumab emtansine for HER2-positive advanced breast cancer.

Nivolumab plus ipilimumab in advanced melanoma.

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

P304

3146-3153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/CC.26060

http://www.w3.org/2001/XMLSchema#string

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24013429

http://www.w3.org/2001/XMLSchema#string

P932

3865009

http://www.w3.org/2001/XMLSchema#string